Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mustang Bio Inc. (MBIO)

  • Company Report
  • Aug. 11, 2022, 13:07 UTC
  • 41

New SEC Form for Mustang Bio, Inc.

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Aug. 11, 2022, 06:20 UTC
  • 30

New SEC Filing for (CIK:0001061027)

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Aug. 11, 2022, 06:20 UTC
  • 40

New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX)

Comment Full text

Cabaletta Bio Inc. (CABA)

  • Company Report
  • Aug. 11, 2022, 04:44 UTC
  • 36

New SEC Form for Cabaletta Bio, Inc.

Comment Full text

Marinus Pharmaceuticals Inc. (MRNS)

  • Company Report
  • Aug. 11, 2022, 04:35 UTC
  • 46

Marinus Pharmaceuticals, Inc. - Second Quarter 2022

Comment Full text

ADMA Biologics Inc (ADMA)

  • Company Report
  • Aug. 10, 2022, 14:29 UTC
  • 33

New SEC Form for ADMA Biologics, Inc.

Comment Full text

Sera Prognostics Inc (SERA)

  • Company Report
  • Aug. 10, 2022, 13:36 UTC
  • 34

New SEC Filing for Sera Prognostics Inc. (NASDAQ:SERA)

Comment Full text

ADMA Biologics Inc (ADMA)

  • Company Report
  • Aug. 10, 2022, 13:11 UTC
  • 36

ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update

Comment Full text

Nuvalent Inc (NUVL)

  • Company Report
  • Aug. 10, 2022, 04:20 UTC
  • 35

New SEC Filing for Nuvalent Inc. (NASDAQ:NUVL)

Comment Full text

Revance Therapeutics (RVNC)

  • Company Report
  • Aug. 09, 2022, 14:48 UTC
  • 43

New Form 10-Q for Revance Therapeutics, Inc.

Comment Full text
  • Previous
  • 62
  • 63
  • 64
  • 65
  • 66
  • Next

Search

News categories

  • Technical Exchange News(9342)
  • Event(407)
  • SEC News(152489)
  • FDA Approval(8712)
  • Company Report(721)
  • Business News(104218)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin